The reporting week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...

In 2023, BMS received a similar approval across the pond. The National Institute for Health and Care Excellence (NICE) ...

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and ...

HALIX, a Dutch contract development and manufacturing organisation (CDMO) specialising in complex therapeutic antibodies and ...

Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...

With only 12% 1 of therapies surviving the gauntlet of Phase III trials to receive FDA approval, and the cost to bring a drug ...

A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging ...

With a three-decade-plus journey in the oncology space, Hevia and Sousa spoke to the company’s developments in lung, bladder, ...

If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...

The approach can be transformative. When patients feel heard and understood, they’re more likely to engage actively and ...